MAJOR SHAREHOLDER ANNOUNCEMENT
Date
11/20/2024 6:31:04 AM
(MENAFN- GlobeNewsWire - Nasdaq) In accordance with section 30 of the Capital Markets Act, Pandora A/S hereby announces that
BlackRock, Inc. has notified the company of its control over voting rights for 7,226,047 shares, representing 8.81% of the total share capital and voting rights (previously 8.81%). Additionally, BlackRock, Inc. controls voting rights attached to financial instruments amounting to 1.18% (previously 1.18%). In total, BlackRock, Inc. controls 9.99% of the company's voting rights (previously 10.00%). ABOUT PANDORA
Pandora is the world's largest jewellery brand. The company designs, manufactures and markets hand-finished jewellery made from high-quality materials at accessible price points. Pandora jewellery is sold in more than 100 countries through 6,700 points of sale, including more than 2,600 concept stores.
Headquartered in Copenhagen, Denmark, Pandora employs 33,000 people worldwide and crafts its jewellery at three facilities in Thailand using only recycled silver and gold. Pandora is committed to leadership in sustainability and has set out to halve greenhouse gas emissions across its value chain by 2030. Pandora is listed on the Nasdaq Copenhagen stock exchange and generated revenue of DKK 28.1 billion (EUR 3.8 billion) in 2023.
Contact
For more information, please contact:
INVESTOR RELATIONS
Bilal Aziz
VP, Investor Relations & Treasury
+45 3137 9486
... | CORPORATE COMMUNICATIONS
Johan Melchior
VP, Media Relations & Public Affairs
+45 4060 1415
... |
Adam Fuglsang
Director, Investor Relations
+45 6167 7425
... | |
| | |
Attachment
Pandora_Company Announcement_No_905
MENAFN20112024004107003653ID1108905894
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.